Abstract
Sabril (vigabatrin) oral solution was approved by the FDA on August 21st, 2009 for treatment of infantile spasms in children ages 1 month to 2 years and complex partial seizures in adults (tablets).
| Original language | English (US) |
|---|---|
| Pages (from-to) | 475 |
| Number of pages | 1 |
| Journal | ACS Chemical Neuroscience |
| Volume | 1 |
| Issue number | 7 |
| DOIs | |
| State | Published - Jul 21 2010 |
| Externally published | Yes |
ASJC Scopus subject areas
- Biochemistry
- Physiology
- Cognitive Neuroscience
- Cell Biology